Momenex (Mometasone Furoate)

Mometasone furoate, the active ingredient in Momenex, is a corticosteroid presented as a nasal spray for nasal use. It treats allergic rhinitis and nasal polyps in adults and children.

GNH USA supplies Momenex as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mometasone furoate nasal spray acts on inflammatory processes of the nasal mucosa to relieve symptoms of allergic and obstructive conditions. - Allergic rhinitis: reduces nasal congestion, itching, and sneezing caused by seasonal or perennial allergens. - Nasal polyps: decreases polyp size and improves nasal airflow. - Seasonal allergic rhinitis: alleviates acute allergy symptoms during high pollen periods.

Mometasone furoate nasal spray may cause local and systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning sensation - Headache - Epistaxis (nosebleed) - Throat irritation or dryness - Cough - Altered taste or bitter taste

Serious or Rare Side Effects: - Nasal septal perforation - Severe allergic reaction (anaphylaxis) - Vision changes or cataract formation - Adrenal suppression with prolonged high‑dose use - Fungal infection of the nasal passages - Increased intra‑ocular pressure or glaucoma exacerbation

Before using Momenex, consider the following safety measures. - Prescription use only: follow the prescriber's instructions. - Recent nasal surgery or trauma: avoid use until healed. - Monitor for signs of infection: discontinue if persistent sinus infection occurs. - Caution in patients with glaucoma or cataracts: assess intra‑ocular pressure regularly. - Known hypersensitivity: do not use if allergic to mometasone or any formulation component. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Mometasone furoate nasal spray can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Systemic corticosteroids: combined use may increase risk of adrenal suppression. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may raise local drug exposure. - Immunosuppressants (e.g., cyclosporine): heightened risk of local infection.

Moderate Interactions (Monitor Closely): - Antihistamines: may reduce perceived benefit of the nasal spray. - Intranasal decongestants: concurrent use can increase nasal irritation.